Colloidal silver history, a story in the making, stretches back thousands of years into the past. Since the dawn of man, many civilizations have recognized the properties of silver in preventing diseases. For instance, the Romans used silver nitrate therapeutically. The hermetic and alchemical writings of Paracelsus speak of the virtues of silver as a healing substance,continuing to be used in the middle ages on the wounds from battles.
The expression 'born with a silver spoon in his mouth', has more to do with colloidal silver history than with wealth. Yes, you need some financial power to outfit a home with solid silver eating utensils, but during the plaques of Europe wealthy families gave their children silver spoons to suck on. Silver coins were placed in drinking water and milk was stored in silver pails in order to prevent spoilage.
In the 1800s, several physicians discovered the antibacterial (antigerm) qualities of silver and applied them to their practice of medicine. They used silver nitrate successfully in the treatment of skin ulcers, compound fractures and suppurating (draining puss) wounds. In 1881, Carl Crede pioneered the installation of dilute silver nitrate in the eye of neonates to prevent gonorrheal ophthalmia, a technique which has been in widespread use ever since. Von Naegeli and others in 1893 realized that the antibacterial effects of silver were primarily due to the silver ion. He coined the term oligodynamic to mean that a small amount of silver is released from the metallic surface when placed in contact with liquids.
At the turn of the century, Dr. William Halstead, one of the founding fathers of modern surgery, advocated the use of silver soil dressings for wounds. These dressings were used extensively until just after World War II, and were listed in the Physician's Desk Reference until 1955, when the use of antibiotics became widespread.
In 1924, the first electro-colloidal silver was produced.
At the time this was very high tech stuff. It seemed that colloidal silver breakthroughs and new technology were just around the corner. Scientists were doing research on the lymphatic fluids taking note they are colloidal in nature creating new possibilities for colloidal silver medicine. A stumbling block however was that the method of creating a colloidal silver consisted of grinding up silver into a powder and placing it in water. This proved to be problematic as the particles would fall to the bottom. A solution was devised to use protein stabilizers to slow the fall of the particles this created a new problem as the chemicals from the protein were removed they left a toxic residue.
Even still colloidal silver was still in widespread use in 1938 when it was known to kill over 650 infectious diseases. Pharmaceutical companies then replaced the heirloom silver for widespread use of modern medicine antibiotics. Naturally, this led to a severe decline in the making of colloidal silver history as the corporate influence led to a severe halt in production, as well as funding for colloidal silver research. These profit based entities realized to protect their monopoly they needed to suppress and hide the benefits of silver.
It became evident during the 1980's that a bacterial resistance was being formed for the synthetic antibiotics produced by the pharmaceutical companies. The first reported cases of community-acquired MRSA began to appear in the mid-1990s from Australia, New Zealand, the United States, the United Kingdom, France, Finland, Canada, and Samoa.
"Antibiotic resistance appeared soon after the introduction of these synthetic drugs in the 1930s. Since then, more and more bacteria have become resistant to more and more antibiotics." The article continues: "Last January, researchers at the Georgetown University School of Medicines Department of Pediatrics monitored 20 children taking amoxicillin daily to prevent ear infections. (Note: Dr. Fallon) The study indicated that while their risk of infection from a resistant germ was 20% before using the antibiotic, after a five-month regimen, they stood a 100% chance of contracting a super bug, a fivefold increase in risk. Four months after those children were taken off amoxicillin, their risk level returned to its original point."
The CDC in Atlanta said that over 70,000 people died in American hospitals in 2000 from infectious conditions that resisted conventional drugs. The medical community has known this for many years!
American Biotech Labs (ABL) was founded in 1998 under the name American Silver LLC. Since that time, the company has changed its name to American Biotech Labs to clearly establish its identity as a bio-medical technology company. Although the concept of using silver is not a new idea, the founders spent years before ABL was incorporated, refining the process to create a far more effective agent that promotes health and well being. The end result was to revolutionize colloidal silver history completely due to the nano engineering in SilverSol technology.